LatestRare Brain Neurons Discovered to Synchronize Brain Activity and Promote Sleep
Cannabis

Missouri Implements Hemp THC Product Restrictions While Federal Ban Remains Delayed

Marijuana Moment
Missouri Implements Hemp THC Product Restrictions While Federal Ban Remains Delayed
Summary

Missouri is moving forward with state-level restrictions on hemp-derived THC products, particularly focusing on regulated beverages and infused drinks, even as a federal ban remains delayed. The state may reassess its regulatory framework in 2027 depending on federal action and potential changes to product formulations. This decision affects companies like Mighty Kind Company, which produces CBD-infused sparkling water and other hemp products. The regulatory approach reflects growing concerns about hemp-derived THC products' accessibility and oversight in states where cannabis remains federally controlled.

Marijuana Moment

Originally published on

Marijuana Moment

By Marijuana Moment

Read full article(opens in new tab)

Fetched: September 13, 2026 at 10:02 AM

Related News

More news you might be interested in

View all
The Cold Stops the Clock: How Fresh Frozen Cannabis Becomes Live Rosin
Cannabis

The Cold Stops the Clock: How Fresh Frozen Cannabis Becomes Live Rosin

Fresh frozen cannabis extraction preserves the plant's terpene profile and color at harvest, maintaining therapeutic compounds that traditional curing methods diminish. Industry experts explain the critical trichome characteristics required for successful fresh frozen processing and the cold chain management challenges that most producers fail to overcome. Live rosin produced from fresh frozen material offers patients a full-spectrum concentrate with enhanced aromatic and flavor profiles. Understanding hash library development and genetic selection is essential for consistent quality. This advancement in extraction technology provides medical users with concentrates that may better preserve the plant's complete cannabinoid and terpene profile for therapeutic benefit.

22 hours ago
High Times
Nanotechnology Revolutionizes Medical Cannabis Delivery in Dermatology
Cannabis
AcneDermatitis

Nanotechnology Revolutionizes Medical Cannabis Delivery in Dermatology

A comprehensive scientific review reveals how nanodelivery systems are transforming topical cannabinoid therapy in dermatology. Phytocannabinoids like CBD offer potent antioxidant, anti-inflammatory, and regulatory properties, but face a critical biological challenge: penetrating the skin's outer barrier (stratum corneum). Nanotechnology overcomes this limitation by dramatically increasing tissue bioavailability of cannabis compounds. This breakthrough has significant implications for treating inflammatory skin conditions, offering patients more effective topical formulations with enhanced therapeutic potential and faster absorption rates.

yesterday
Soft Secrets (Español)
Arthritis and Cannabis: Why CBD Alone Falls Short and THC Makes the Difference
Cannabis
ArthritisChronic Pain

Arthritis and Cannabis: Why CBD Alone Falls Short and THC Makes the Difference

A rigorous Danish clinical trial published in the Journal of Cannabis Research reveals that CBD monotherapy at low doses is insufficient for managing chronic pain in rheumatological conditions like rheumatoid arthritis and ankylosing spondylitis. Even when serology tests show controlled joint inflammation, patients often experience persistent severe pain, morning stiffness, and fatigue—challenges that CBD alone cannot adequately address. The research demonstrates that THC-containing formulations provide additional therapeutic value beyond isolated CBD, challenging the widespread commercial narrative that cannabidiol is a universal solution. For Puerto Rico's arthritis patients seeking medical marijuana options, this finding underscores the importance of comprehensive cannabinoid profiles rather than single-compound approaches.

yesterday
Soft Secrets (Español)
Prehistoric High: 25,000-Year-Old Teeth Reveal Oldest Evidence of Psychoactive Drug Use
Cannabis

Prehistoric High: 25,000-Year-Old Teeth Reveal Oldest Evidence of Psychoactive Drug Use

Researchers have discovered traces of arecoline in ancient teeth from Indonesia, providing evidence that humans may have used psychoactive areca nuts as far back as 25,000 years ago. This groundbreaking discovery pushes back the timeline of deliberate psychoactive substance use in human history by thousands of years. The findings suggest that the human desire to alter consciousness through plant-based compounds is deeply rooted in our evolutionary past. Understanding historical patterns of substance use helps modern researchers contextualize the role of psychoactive compounds in human culture and medicine.

yesterday
High Times